[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2023609A6 - Process for obtaining 2-[[[3-methyl-4-(2,2,2- trifluoroethoxy)-2-pyridinyl]methyl]sulphinyl]-1H- benzimidazole - Google Patents

Process for obtaining 2-[[[3-methyl-4-(2,2,2- trifluoroethoxy)-2-pyridinyl]methyl]sulphinyl]-1H- benzimidazole

Info

Publication number
ES2023609A6
ES2023609A6 ES9003047A ES9003047A ES2023609A6 ES 2023609 A6 ES2023609 A6 ES 2023609A6 ES 9003047 A ES9003047 A ES 9003047A ES 9003047 A ES9003047 A ES 9003047A ES 2023609 A6 ES2023609 A6 ES 2023609A6
Authority
ES
Spain
Prior art keywords
methyl
sulphinyl
pyridinyl
benzimidazole
trifluoroethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9003047A
Other languages
Spanish (es)
Inventor
Rovira Ana Bosch
Barjoan Pere Dalmases
Olondriz Francisco Marquillas
Ges Jose Maria Caldero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quimica Sintetica SA
Original Assignee
Inke SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inke SA filed Critical Inke SA
Priority to ES9003047A priority Critical patent/ES2023609A6/en
Publication of ES2023609A6 publication Critical patent/ES2023609A6/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Process for obtaining 2-[[[3-methyl-4-(2,2,2- trifluoroethoxy)-2-pyridinyl]methyl]sulphinyl]-1H- benzimidazole. Comprises replacing the salient group in the 4 position of the pyridine in substituted 2-[[(3-methyl-2- pyridinyl)methyl]sulphinyl]-1H-benzimidazole derivatives by 2,2,2-trifluoroethanol in order to obtain the desired product which is isolated from the reaction mixture by conventional means. The product obtained has useful therapeutic properties deriving from its activities as an inhibitor of the secretion of gastric acid and its antiulcer activity.
ES9003047A 1990-11-29 1990-11-29 Process for obtaining 2-[[[3-methyl-4-(2,2,2- trifluoroethoxy)-2-pyridinyl]methyl]sulphinyl]-1H- benzimidazole Expired - Fee Related ES2023609A6 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9003047A ES2023609A6 (en) 1990-11-29 1990-11-29 Process for obtaining 2-[[[3-methyl-4-(2,2,2- trifluoroethoxy)-2-pyridinyl]methyl]sulphinyl]-1H- benzimidazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9003047A ES2023609A6 (en) 1990-11-29 1990-11-29 Process for obtaining 2-[[[3-methyl-4-(2,2,2- trifluoroethoxy)-2-pyridinyl]methyl]sulphinyl]-1H- benzimidazole

Publications (1)

Publication Number Publication Date
ES2023609A6 true ES2023609A6 (en) 1992-01-16

Family

ID=8269833

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9003047A Expired - Fee Related ES2023609A6 (en) 1990-11-29 1990-11-29 Process for obtaining 2-[[[3-methyl-4-(2,2,2- trifluoroethoxy)-2-pyridinyl]methyl]sulphinyl]-1H- benzimidazole

Country Status (1)

Country Link
ES (1) ES2023609A6 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2036948A1 (en) * 1991-11-21 1993-06-01 Genesis Para La Investigacion Procedure for obtaining compounds derived from pyridine.
ES2037609A1 (en) * 1991-12-02 1993-06-16 Techquin Etablissment 1H-benzimidazole deriv. prepn.
ES2037608A1 (en) * 1991-12-02 1993-06-16 Techquin Etablissment 2(((3-Methyl-New 1H-benzimidazole deriv. prepn.
ES2058027A1 (en) * 1991-11-21 1994-10-16 Genesis Para La Investigacion Improvements in the object of Patent 9102594 for Procedure for obtaining compounds derived from pyridine
ES2060541A1 (en) * 1993-02-26 1994-11-16 Vinas Lab New procedure for the synthesis of a derivative of 2-(2- pyridylmethylsulphinyl)benzimidazole, and new intermediate products obtained therewith
ES2063705A1 (en) * 1993-06-14 1995-01-01 S A L V A T Lab Sa Intermediate for the synthesis of lansoprazole and procedure for obtaining it
WO2001004109A1 (en) * 1999-07-14 2001-01-18 Quimica Sintetica, S.A. Process for the production of 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles
ES2187248A1 (en) * 2000-08-25 2003-05-16 Sint Quimica Sa Procedure is for obtaining derivatives of 2-(2-pyridinyl methyl-sulphinyl)-benzimidazole to be used in treatment or prevention of peptic ulcers
WO2005054228A1 (en) * 2003-12-05 2005-06-16 Hetero Drugs Limited A process for the preparation of substitited pyridinylmethylsulfinyl- benzimidazole enantiomers
ES2264362A1 (en) * 2004-12-22 2006-12-16 Laboratorios Viñas S.A. Procedure is for obtaining derivatives of 2-(2-) pyridinil-methylsulfinil-1H-benzimidazols of general formula useful as inhibitors of acid secretion or as anti-ulcerous agents
ITMI20082046A1 (en) * 2008-11-18 2010-05-19 Dipharma Francis Srl PROCEDURE FOR THE PREPARATION OF DEXLANSOPRAZOL
US8314241B2 (en) 2009-07-29 2012-11-20 Dipharma Francis S.R.L. Process for the preparation of crystalline dexlansoprazole

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2105953A1 (en) * 1991-11-21 1997-10-16 Genesis Para La Investigacion Procedure for obtaining compounds derived from pyridine.
ES2036948A1 (en) * 1991-11-21 1993-06-01 Genesis Para La Investigacion Procedure for obtaining compounds derived from pyridine.
ES2058027A1 (en) * 1991-11-21 1994-10-16 Genesis Para La Investigacion Improvements in the object of Patent 9102594 for Procedure for obtaining compounds derived from pyridine
ES2037608A1 (en) * 1991-12-02 1993-06-16 Techquin Etablissment 2(((3-Methyl-New 1H-benzimidazole deriv. prepn.
ES2037609A1 (en) * 1991-12-02 1993-06-16 Techquin Etablissment 1H-benzimidazole deriv. prepn.
ES2060541A1 (en) * 1993-02-26 1994-11-16 Vinas Lab New procedure for the synthesis of a derivative of 2-(2- pyridylmethylsulphinyl)benzimidazole, and new intermediate products obtained therewith
ES2063705A1 (en) * 1993-06-14 1995-01-01 S A L V A T Lab Sa Intermediate for the synthesis of lansoprazole and procedure for obtaining it
ES2166269A1 (en) * 1999-07-14 2002-04-01 Sint Quimica Sa Process for the production of 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles
WO2001004109A1 (en) * 1999-07-14 2001-01-18 Quimica Sintetica, S.A. Process for the production of 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles
ES2187248A1 (en) * 2000-08-25 2003-05-16 Sint Quimica Sa Procedure is for obtaining derivatives of 2-(2-pyridinyl methyl-sulphinyl)-benzimidazole to be used in treatment or prevention of peptic ulcers
WO2005054228A1 (en) * 2003-12-05 2005-06-16 Hetero Drugs Limited A process for the preparation of substitited pyridinylmethylsulfinyl- benzimidazole enantiomers
ES2264362A1 (en) * 2004-12-22 2006-12-16 Laboratorios Viñas S.A. Procedure is for obtaining derivatives of 2-(2-) pyridinil-methylsulfinil-1H-benzimidazols of general formula useful as inhibitors of acid secretion or as anti-ulcerous agents
ITMI20082046A1 (en) * 2008-11-18 2010-05-19 Dipharma Francis Srl PROCEDURE FOR THE PREPARATION OF DEXLANSOPRAZOL
US8198455B2 (en) 2008-11-18 2012-06-12 Dipharma Francis S.R.L. Process for the preparation of dexlansoprazole
US8314241B2 (en) 2009-07-29 2012-11-20 Dipharma Francis S.R.L. Process for the preparation of crystalline dexlansoprazole

Similar Documents

Publication Publication Date Title
US5703097A (en) 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
ES2023609A6 (en) Process for obtaining 2-[[[3-methyl-4-(2,2,2- trifluoroethoxy)-2-pyridinyl]methyl]sulphinyl]-1H- benzimidazole
UA32524C2 (en) A process for preparation of omeprazole
NZ330816A (en) Quinazoline derivatives as antitumor agents
NZ511377A (en) New crystalline form of omeprazole
IL99571A (en) Process for the preparation of water soluble 10-hydroxy-9-(substituted methyl)camptothecin analogs
PL246492A1 (en) Process for preparing novel salts of 5-methoxy-2-(/(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl/ sulfinyl)-1h-benzimidazole
RU95105587A (en) Optically pure compounds of pyridinylmethyl-sulfinyl-1h-benzimidazole, their salts, methods of synthesis, pharmcomposition, treatment method
ES8600300A1 (en) Diuretic, antihypertensive and antihistaminic 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
US4548940A (en) Pyridylaminoalkylaminopyrimidones useful as histamine H1 -antagonists
PT75074A (en) Process for preparing cestain pyrimidone derivatives and composition containing their
ES2060541A1 (en) New procedure for the synthesis of a derivative of 2-(2- pyridylmethylsulphinyl)benzimidazole, and new intermediate products obtained therewith
LTIP1722A (en) Therapeutically active substituted benzimidazole and process for its preparation
HRP20030853A2 (en) Crystalline form of omeprazole
SI1095037T2 (en) Process of synthesis of 5-methoxy- 2- (4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl)sulfinyl-1h-benzimidazole
JP5448448B2 (en) Isotope-substituted proton pump inhibitor
HU901095D0 (en) Process for producing compound reducing extraction of gastric acid and pharmaceutical preparative containing said compound
CA2014062A1 (en) Pyridine derivatives
NO165195C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NEW DERIVATIVES OF 4,5-DIHYDRO-OXSAZOLYL-2 - ((2-PYRIDYL) -METHYL-THIO- OR METHYLSULPHINYL) -BENZ- OR TIENOIDID.
ES2063705A1 (en) Intermediate for the synthesis of lansoprazole and procedure for obtaining it
CS250249B2 (en) Method of imidazole's tricyclic derivatives production
WO1997032854A1 (en) 2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient
Yum et al. Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo [3, 2-c] quinolines
KR910008938B1 (en) Process for preparing of pyridine derivertes
KR101137168B1 (en) Pyrrolo[2,3-d]pyridazine derivatives and processes for the preparation thereof

Legal Events

Date Code Title Description
PC1A Transfer granted

Owner name: QUIMICA SINTETICA, S.A. (TITULAR DEL 50%)

GC1A Exploitation certificate registered application without search report

Effective date: 19961025

PC1A Transfer granted
FD2A Announcement of lapse in spain

Effective date: 20110301